Hungarian Gedeon Richter and Irish Allergan are staying on course in the face of dissappointing Phase III...
Up To Date
Latest News
Araclon Biotech’s Alzheimer’s vaccine ABvac40 is going forward into Phase II after showing a good safety...
After a two-year pilot period, the EMA has published its report on its adaptive pathways approach. The agency...
Life science venture capital group Epidarex has launched Nodthera Ltd, a biotech based on research by...
GlaxoSmithKline has in-licensed Janssen’s anti-IL-33R monoclonal antibody for severe asthma. The British...
In view of the Brexit, research academies across Britain are calling for a “bold commitment” from the...